nodes	percent_of_prediction	percent_of_DWPC	metapath
Buclizine—HRH1—atherosclerosis	0.506	1	CbGaD
Buclizine—Fluspirilene—Ezetimibe—atherosclerosis	0.269	0.552	CrCrCtD
Buclizine—Flunarizine—Ezetimibe—atherosclerosis	0.218	0.448	CrCrCtD
Buclizine—Cetirizine—HRH1—atherosclerosis	0.000575	0.124	CrCbGaD
Buclizine—Chlorcyclizine—HRH1—atherosclerosis	0.000524	0.113	CrCbGaD
Buclizine—Meclizine—HRH1—atherosclerosis	0.000481	0.104	CrCbGaD
Buclizine—Clemastine—HRH1—atherosclerosis	0.000452	0.0978	CrCbGaD
Buclizine—Hydroxyzine—HRH1—atherosclerosis	0.000444	0.096	CrCbGaD
Buclizine—Imatinib—CSF1R—atherosclerosis	0.000418	0.0906	CrCbGaD
Buclizine—Fluspirilene—HRH1—atherosclerosis	0.000319	0.0692	CrCbGaD
Buclizine—Fexofenadine—HRH1—atherosclerosis	0.000313	0.0678	CrCbGaD
Buclizine—Cyclizine—HRH1—atherosclerosis	0.0003	0.0649	CrCbGaD
Buclizine—Azelastine—HRH1—atherosclerosis	0.000265	0.0573	CrCbGaD
Buclizine—Flunarizine—HRH1—atherosclerosis	0.000259	0.0561	CrCbGaD
Buclizine—Cinnarizine—HRH1—atherosclerosis	0.000205	0.0443	CrCbGaD
Buclizine—Imatinib—ALB—atherosclerosis	6.3e-05	0.0137	CrCbGaD
Buclizine—CHRM1—Signaling by GPCR—HRH1—atherosclerosis	7.18e-06	0.00353	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	7.04e-06	0.00346	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	7.02e-06	0.00345	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	7e-06	0.00344	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	6.98e-06	0.00343	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—CCL3—atherosclerosis	6.93e-06	0.00341	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—CCL3—atherosclerosis	6.91e-06	0.0034	CbGpPWpGaD
Buclizine—HRH1—G alpha (q) signalling events—F2—atherosclerosis	6.87e-06	0.00338	CbGpPWpGaD
Buclizine—CHRM1—Circadian rythm related genes—LEP—atherosclerosis	6.86e-06	0.00337	CbGpPWpGaD
Buclizine—CHRM1—G alpha (q) signalling events—F2—atherosclerosis	6.85e-06	0.00337	CbGpPWpGaD
Buclizine—HRH1—IL-4 Signaling Pathway—AKT1—atherosclerosis	6.78e-06	0.00334	CbGpPWpGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—atherosclerosis	6.65e-06	0.00327	CbGpPWpGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—atherosclerosis	6.63e-06	0.00326	CbGpPWpGaD
Buclizine—CHRM1—Circadian rythm related genes—NOS2—atherosclerosis	6.39e-06	0.00314	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—CCR2—atherosclerosis	6.27e-06	0.00308	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—EDNRA—atherosclerosis	6.27e-06	0.00308	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—CCR2—atherosclerosis	6.25e-06	0.00307	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—EDNRA—atherosclerosis	6.25e-06	0.00307	CbGpPWpGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—atherosclerosis	6.15e-06	0.00302	CbGpPWpGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—atherosclerosis	6.13e-06	0.00301	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—GHRL—atherosclerosis	6.11e-06	0.00301	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—GHRL—atherosclerosis	6.09e-06	0.003	CbGpPWpGaD
Buclizine—CHRM1—Circadian rythm related genes—PPARG—atherosclerosis	5.97e-06	0.00294	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	5.94e-06	0.00292	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	5.92e-06	0.00291	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	5.89e-06	0.0029	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	5.87e-06	0.00289	CbGpPWpGaD
Buclizine—CHRM1—Circadian rythm related genes—SERPINE1—atherosclerosis	5.38e-06	0.00265	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—KNG1—atherosclerosis	5.36e-06	0.00264	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—KNG1—atherosclerosis	5.35e-06	0.00263	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—AGTR1—atherosclerosis	5.33e-06	0.00262	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—AGTR1—atherosclerosis	5.31e-06	0.00261	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—CCL4—atherosclerosis	5.21e-06	0.00256	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—CCL4—atherosclerosis	5.19e-06	0.00255	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—UTS2—atherosclerosis	5.11e-06	0.00251	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—UTS2—atherosclerosis	5.1e-06	0.00251	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	4.93e-06	0.00242	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	4.91e-06	0.00242	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—CASR—atherosclerosis	4.9e-06	0.00241	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—CASR—atherosclerosis	4.89e-06	0.0024	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—UTS2—atherosclerosis	4.64e-06	0.00228	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—UTS2—atherosclerosis	4.63e-06	0.00228	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—CNR2—atherosclerosis	4.56e-06	0.00224	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	4.55e-06	0.00224	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—CNR2—atherosclerosis	4.54e-06	0.00223	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	4.54e-06	0.00223	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—EDN1—atherosclerosis	4.52e-06	0.00222	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—EDN1—atherosclerosis	4.51e-06	0.00222	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—CCL5—atherosclerosis	4.49e-06	0.00221	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—CCL5—atherosclerosis	4.47e-06	0.0022	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—CX3CR1—atherosclerosis	4.45e-06	0.00219	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—CASR—atherosclerosis	4.45e-06	0.00219	CbGpPWpGaD
Buclizine—CHRM1—Regulation of Actin Cytoskeleton—MAPK3—atherosclerosis	4.45e-06	0.00219	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—CX3CR1—atherosclerosis	4.44e-06	0.00218	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—CASR—atherosclerosis	4.44e-06	0.00218	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—CX3CL1—atherosclerosis	4.37e-06	0.00215	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—CX3CL1—atherosclerosis	4.35e-06	0.00214	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—HRH1—atherosclerosis	4.24e-06	0.00209	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—CNR2—atherosclerosis	4.14e-06	0.00204	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—CNR2—atherosclerosis	4.12e-06	0.00203	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	4.06e-06	0.002	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	4.04e-06	0.00199	CbGpPWpGaD
Buclizine—CHRM1—Circadian rythm related genes—MAPK8—atherosclerosis	4.01e-06	0.00197	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—AGT—atherosclerosis	3.75e-06	0.00185	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—AGT—atherosclerosis	3.74e-06	0.00184	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—CCL3—atherosclerosis	3.56e-06	0.00175	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—CCL3—atherosclerosis	3.55e-06	0.00174	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—CCR2—atherosclerosis	3.54e-06	0.00174	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—EDNRA—atherosclerosis	3.54e-06	0.00174	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—EDNRA—atherosclerosis	3.53e-06	0.00174	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—CCR2—atherosclerosis	3.53e-06	0.00174	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—F2—atherosclerosis	3.47e-06	0.00171	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—F2—atherosclerosis	3.46e-06	0.0017	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—GHRL—atherosclerosis	3.45e-06	0.0017	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—GHRL—atherosclerosis	3.44e-06	0.00169	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—APOA4—atherosclerosis	3.34e-06	0.00164	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—APOA4—atherosclerosis	3.33e-06	0.00164	CbGpPWpGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	3.33e-06	0.00164	CbGpPWpGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	3.32e-06	0.00163	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—CCR2—atherosclerosis	3.22e-06	0.00158	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—EDNRA—atherosclerosis	3.22e-06	0.00158	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	3.21e-06	0.00158	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—CCR2—atherosclerosis	3.21e-06	0.00158	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—EDNRA—atherosclerosis	3.21e-06	0.00158	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	3.2e-06	0.00157	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—GHRL—atherosclerosis	3.14e-06	0.00154	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—GHRL—atherosclerosis	3.13e-06	0.00154	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—CCL2—atherosclerosis	3.09e-06	0.00152	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—CCL2—atherosclerosis	3.08e-06	0.00151	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CCL4—atherosclerosis	3.08e-06	0.00151	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CCL4—atherosclerosis	3.07e-06	0.00151	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—KNG1—atherosclerosis	3.03e-06	0.00149	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—KNG1—atherosclerosis	3.02e-06	0.00149	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—AGTR1—atherosclerosis	3.01e-06	0.00148	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—AGTR1—atherosclerosis	3e-06	0.00148	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—APOA2—atherosclerosis	2.87e-06	0.00141	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—APOA2—atherosclerosis	2.87e-06	0.00141	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—KNG1—atherosclerosis	2.75e-06	0.00135	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—KNG1—atherosclerosis	2.74e-06	0.00135	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—UTS2—atherosclerosis	2.74e-06	0.00135	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—AGTR1—atherosclerosis	2.74e-06	0.00135	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—UTS2—atherosclerosis	2.73e-06	0.00134	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—AGTR1—atherosclerosis	2.73e-06	0.00134	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CX3CR1—atherosclerosis	2.63e-06	0.00129	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CASR—atherosclerosis	2.63e-06	0.00129	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CX3CR1—atherosclerosis	2.62e-06	0.00129	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CASR—atherosclerosis	2.62e-06	0.00129	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CX3CL1—atherosclerosis	2.58e-06	0.00127	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CX3CL1—atherosclerosis	2.57e-06	0.00126	CbGpPWpGaD
Buclizine—CHRM1—Circadian rythm related genes—IL6—atherosclerosis	2.56e-06	0.00126	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—EDN1—atherosclerosis	2.55e-06	0.00126	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—EDN1—atherosclerosis	2.55e-06	0.00125	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—CCL5—atherosclerosis	2.53e-06	0.00125	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—CCL5—atherosclerosis	2.53e-06	0.00124	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CNR2—atherosclerosis	2.44e-06	0.0012	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—CXCL8—atherosclerosis	2.44e-06	0.0012	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—MMP3—atherosclerosis	2.44e-06	0.0012	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CNR2—atherosclerosis	2.44e-06	0.0012	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—CXCL8—atherosclerosis	2.44e-06	0.0012	CbGpPWpGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	2.43e-06	0.0012	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—MMP3—atherosclerosis	2.43e-06	0.0012	CbGpPWpGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	2.43e-06	0.00119	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—PRKCG—atherosclerosis	2.41e-06	0.00119	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—PRKCG—atherosclerosis	2.4e-06	0.00118	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—EDN1—atherosclerosis	2.32e-06	0.00114	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—EDN1—atherosclerosis	2.31e-06	0.00114	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—CCL5—atherosclerosis	2.3e-06	0.00113	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—CCL5—atherosclerosis	2.29e-06	0.00113	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—PRKCG—atherosclerosis	2.19e-06	0.00108	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—PRKCG—atherosclerosis	2.18e-06	0.00107	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—VWF—atherosclerosis	2.18e-06	0.00107	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—VWF—atherosclerosis	2.17e-06	0.00107	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—APOC3—atherosclerosis	2.17e-06	0.00106	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—APOC3—atherosclerosis	2.16e-06	0.00106	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—LDLR—atherosclerosis	2.15e-06	0.00106	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—LDLR—atherosclerosis	2.15e-06	0.00106	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—AGT—atherosclerosis	2.12e-06	0.00104	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—AGT—atherosclerosis	2.11e-06	0.00104	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CCL3—atherosclerosis	2.1e-06	0.00103	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CCL3—atherosclerosis	2.1e-06	0.00103	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—NCF1—atherosclerosis	2.01e-06	0.00099	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—NCF1—atherosclerosis	2.01e-06	0.000987	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—F2—atherosclerosis	1.96e-06	0.000964	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—F2—atherosclerosis	1.95e-06	0.000961	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—AGT—atherosclerosis	1.93e-06	0.000947	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—AGT—atherosclerosis	1.92e-06	0.000944	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—EDNRA—atherosclerosis	1.9e-06	0.000935	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CCR2—atherosclerosis	1.9e-06	0.000935	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CCR2—atherosclerosis	1.89e-06	0.000932	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—EDNRA—atherosclerosis	1.89e-06	0.000932	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CYBA—atherosclerosis	1.89e-06	0.000931	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CYBA—atherosclerosis	1.89e-06	0.000928	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—PIK3CG—atherosclerosis	1.87e-06	0.000922	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	1.87e-06	0.000919	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—GHRL—atherosclerosis	1.85e-06	0.000911	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PARP1—atherosclerosis	1.85e-06	0.000911	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PLAT—atherosclerosis	1.85e-06	0.000911	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PARP1—atherosclerosis	1.85e-06	0.000908	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—GHRL—atherosclerosis	1.85e-06	0.000908	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PLAT—atherosclerosis	1.85e-06	0.000908	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—F2—atherosclerosis	1.78e-06	0.000875	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—F2—atherosclerosis	1.77e-06	0.000872	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—PIK3CG—atherosclerosis	1.7e-06	0.000837	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	1.7e-06	0.000835	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—KNG1—atherosclerosis	1.63e-06	0.0008	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—KNG1—atherosclerosis	1.62e-06	0.000797	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—AGTR1—atherosclerosis	1.62e-06	0.000795	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	1.61e-06	0.000792	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—CCL2—atherosclerosis	1.59e-06	0.00078	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	1.58e-06	0.000777	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PLG—atherosclerosis	1.58e-06	0.000775	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PLG—atherosclerosis	1.57e-06	0.000772	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—SOCS3—atherosclerosis	1.49e-06	0.000734	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	1.49e-06	0.000731	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—MMP3—atherosclerosis	1.44e-06	0.000709	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—MMP3—atherosclerosis	1.44e-06	0.000706	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—IGF2—atherosclerosis	1.43e-06	0.000705	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—IGF2—atherosclerosis	1.43e-06	0.000703	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—APOB—atherosclerosis	1.39e-06	0.000685	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—APOB—atherosclerosis	1.39e-06	0.000683	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—CXCL8—atherosclerosis	1.38e-06	0.000679	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	1.38e-06	0.000677	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—EDN1—atherosclerosis	1.37e-06	0.000674	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—EDN1—atherosclerosis	1.37e-06	0.000672	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CCL5—atherosclerosis	1.36e-06	0.000669	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CCL5—atherosclerosis	1.36e-06	0.000667	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—LPL—atherosclerosis	1.33e-06	0.000654	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—LPL—atherosclerosis	1.33e-06	0.000652	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PRKCG—atherosclerosis	1.29e-06	0.000636	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	1.29e-06	0.000634	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—SPP1—atherosclerosis	1.26e-06	0.000619	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—SPP1—atherosclerosis	1.26e-06	0.000617	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—CXCL8—atherosclerosis	1.25e-06	0.000617	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	1.25e-06	0.000615	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PDGFB—atherosclerosis	1.17e-06	0.000573	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	1.16e-06	0.000571	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—AGT—atherosclerosis	1.14e-06	0.000559	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—AGT—atherosclerosis	1.13e-06	0.000558	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—LEP—atherosclerosis	1.11e-06	0.000548	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—APOE—atherosclerosis	1.11e-06	0.000548	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—APOE—atherosclerosis	1.11e-06	0.000546	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—LEP—atherosclerosis	1.11e-06	0.000546	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CAV1—atherosclerosis	1.1e-06	0.000543	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—APOA1—atherosclerosis	1.1e-06	0.000542	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CAV1—atherosclerosis	1.1e-06	0.000541	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—APOA1—atherosclerosis	1.1e-06	0.00054	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—ESR1—atherosclerosis	1.06e-06	0.000523	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—ESR1—atherosclerosis	1.06e-06	0.000522	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—F2—atherosclerosis	1.05e-06	0.000517	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—F2—atherosclerosis	1.05e-06	0.000515	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PIK3CG—atherosclerosis	1.01e-06	0.000495	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	1e-06	0.000493	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—MAPK3—atherosclerosis	9.63e-07	0.000474	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	9.6e-07	0.000472	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—INS—atherosclerosis	9.52e-07	0.000468	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—INS—atherosclerosis	9.49e-07	0.000467	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CCL2—atherosclerosis	9.37e-07	0.000461	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CCL2—atherosclerosis	9.34e-07	0.000459	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—IGF1—atherosclerosis	9.21e-07	0.000453	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—IGF1—atherosclerosis	9.18e-07	0.000451	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	8.75e-07	0.00043	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	8.72e-07	0.000429	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—NOS3—atherosclerosis	8.35e-07	0.000411	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—NOS3—atherosclerosis	8.32e-07	0.000409	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	7.41e-07	0.000364	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	7.38e-07	0.000363	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	7.15e-07	0.000352	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	7.13e-07	0.000351	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—IL6—atherosclerosis	7.04e-07	0.000346	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—IL6—atherosclerosis	7.02e-07	0.000345	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—MMP9—atherosclerosis	6.7e-07	0.000329	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—MMP9—atherosclerosis	6.68e-07	0.000328	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	6.63e-07	0.000326	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	6.61e-07	0.000325	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	6.51e-07	0.00032	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	6.5e-07	0.00032	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	6.49e-07	0.000319	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	6.48e-07	0.000319	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	6.02e-07	0.000296	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	6e-07	0.000295	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—STAT3—atherosclerosis	5.96e-07	0.000293	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—STAT3—atherosclerosis	5.94e-07	0.000292	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	5.69e-07	0.00028	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	5.67e-07	0.000279	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	5.52e-07	0.000272	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	5.5e-07	0.000271	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—IL6—atherosclerosis	4.16e-07	0.000205	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—IL6—atherosclerosis	4.15e-07	0.000204	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—AKT1—atherosclerosis	3.84e-07	0.000189	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—AKT1—atherosclerosis	3.83e-07	0.000188	CbGpPWpGaD
